BRAF (gene)
Top View
- Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma
- Targeting TBK1 Inhibits Migration and Resistance to MEK Inhibitors in Mutant NRAS Melanoma
- Target Genes Regulated by Hsa-Mir-21, by Hsa-Mir-203, by Hsa-Mir-21 and by Hsa-Mir-143
- Comprehensive Review on the Clinical Relevance of Long Non-Coding Rnas in Cutaneous Melanoma
- Hereditary Cancer Panel Descriptions
- Management of Intracranial Melanomas in the Era of Precision Medicine
- Analysis of Mtor Gene Aberrations in Melanoma Patients and Evaluation
- And BRAFV600E-Induced Transformation of Murine Pancreatic Epithelial Cells Requires MEK/ERK-Stimulated IGF1R Signaling
- BRAF Cooperates with PI3K Signaling, Independent of AKT, to Regulate
- Signature BRAF Mutations Kit Protocol Guide
- Pkc Epsilon Is Required for Kras-Driven Lung Tumorigenesis
- Mutations in the RAS-BRAF-MAPK-ERK Pathway
- Overcoming Resistance to BRAF Inhibitors
- Genetic Inactivation Or Pharmacological Inhibition of Pdk1 Delays Development and Inhibits Metastasis of Braf V600E::Pten–/– Melanoma
- MEK Inhibitors Block Growth of Lung Tumours with Mutations in Ataxia–Telangiectasia Mutated
- BRAF Testing for Colorectal Cancer
- Genomic Profiling and New Immunotherapies: an Oncologist’S Perspective
- Dual Inhibition of BRAF and Mtor in BRAFV600E-Mutant Pediatric, Adolescent, and Young Adult Brain Tumors